https://www.selleckchem.com/MEK.html
Computational approaches have been proven to be complementary tools of interest for identifying potential candidates for drug repurposing. However, although the methods developed so far offer interesting opportunities and could contribute to solve issues faced by the pharmaceutical sector, they also come with their own constraints. Indeed, specific challenges ranging from data access, standardization and integration to the implementation of reliable and coherent validation methods must be addressed to allow a systematic use at a larger scale. In thi
Like
Comment
Share
